Literature DB >> 11739910

Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction.

J J Strik1, A Honig, R Lousberg, J Denollet.   

Abstract

This study evaluated screening abilities of self-report questionnaires for depression in first myocardial infarction (MI) patients. One month post-MI, 206 patients with first MI were screened for major and minor depression using the 90-item Symptom Check List (SCL-90), the Beck Depression Inventory (BDI), the Hospital Anxiety and Depression Scale (HADS), and the 17-item Hamilton Depression Rating Scale (Ham-D). The Structured Clinical Interview for DSM-IV criteria was used as the gold standard. Sensitivity and specificity for different cutoff points, using relative operating characteristics curves, were assessed. The internal consistency for all scales was good. When screening for major and minor depression, the optimal cutoff scores are lower than those for screening major depression only. The SCL-90, BDI, HADS, and Ham-D proved to have acceptable abilities for screening post-MI major and minor depression.

Entities:  

Mesh:

Year:  2001        PMID: 11739910     DOI: 10.1176/appi.psy.42.5.423

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  51 in total

1.  Validity of the Beck Depression Inventory as a screening tool for a clinical mood disorder in bariatric surgery candidates.

Authors:  Melissa J Hayden; Wendy A Brown; Leah Brennan; Paul E O'Brien
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

2.  Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome.

Authors:  Ian M Kronish; Nina Rieckmann; Daichi Shimbo; Matthew Burg; Karina W Davidson
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

3.  Classes of depression, anxiety, and functioning in acute coronary syndrome patients.

Authors:  Mayra Tisminetzky; Bethany C Bray; Ruben Miozzo; Onesky Aupont; Thomas McLaughlin
Journal:  Am J Health Behav       Date:  2012-01

4.  Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes.

Authors:  Gloria M Reeves; Kelly J Rohan; Patricia Langenberg; Soren Snitker; Teodor T Postolache
Journal:  J Affect Disord       Date:  2012-01-25       Impact factor: 4.839

5.  Comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. (2006) depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia; 49: 837-845.

Authors:  P de Jonge; J G M Rosmalen
Journal:  Diabetologia       Date:  2006-08-18       Impact factor: 10.122

6.  Broadband behavior rating scales as screeners for autism?

Authors:  Carl L Myers; Amber D Gross; Brandy M McReynolds
Journal:  J Autism Dev Disord       Date:  2014-06

7.  Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes.

Authors:  Ian M Kronish; Nina Rieckmann; Ethan A Halm; Daichi Shimbo; David Vorchheimer; Donald C Haas; Karina W Davidson
Journal:  J Gen Intern Med       Date:  2006-08-09       Impact factor: 5.128

8.  Poor social support is associated with increases in depression but not anxiety over 2 years in heart failure outpatients.

Authors:  Erika Friedmann; Heesook Son; Sue A Thomas; Deborah W Chapa; Hyeon Joo Lee
Journal:  J Cardiovasc Nurs       Date:  2014 Jan-Feb       Impact factor: 2.083

9.  Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit.

Authors:  Gastão L F Soares-Filho; Rafael C Freire; Karla Biancha; Ticiana Pacheco; André Volschan; Alexandre M Valença; Antonio E Nardi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Functional status outcomes in mothers with and without postpartum depression.

Authors:  Bobbie Posmontier
Journal:  J Midwifery Womens Health       Date:  2008 Jul-Aug       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.